-
COST-UTILITY OF TENOFOVIR DISOPROXIL FUMARATE VERSUS ENTECAVIR FOR CHRONIC HEPATITIS B IN INDIA: A MARKOV STATE-TRANSITION MODEL
Mar 18, 2026, 21:38 PM -
TREND IN OPEN AND LAPAROSCOPIC APPENDECTOMY RATES ACROSS CENTRAL AND EASTERN EUROPEAN COUNTRIES (2015-2024)
Mar 18, 2026, 21:38 PM -
CLINICAL AND ECONOMIC BURDEN ASSOCIATED WITH PROLONGED AIR LEAKS AMONG PATIENTS UNDERGOING WEDGE/SEGMENTECTOMY: A RETROSPECTIVE DATABASE ANALYSIS
Mar 18, 2026, 21:38 PM -
STUDY ON THE ACCESSIBILITY OF ORPHAN DRUGS IN CHINA'S URBAN CUSTOMIZED COMMERCIAL MEDICAL INSURANCE
Mar 18, 2026, 21:38 PM -
USING EXTENDED COX MODELS WITH TIME-VARYING COVARIATES TO EXAMINE EFFECT OF VARIABLE OPIOID EXPOSURE IN CANCER RECURRENCE IN DISEASE-FREE BREAST CANCER SURVIVORS
Mar 18, 2026, 21:38 PM -
REAL-WORLD ECONOMIC BURDEN AND HEALTHCARE UTILIZATION DRIVERS IN AUTISM SPECTRUM DISORDER: A LONGITUDINAL ANALYSIS OF EHR AND CLAIMS DATA (2017-2025)
Mar 18, 2026, 21:38 PM -
COST PER CLINICAL WEIGHT-LOSS GOAL ACHIEVEMENT WITH SEMAGLUTIDE 2.4 MG VERSUS LIRAGLUTIDE 3 MG FROM A COLOMBIAN INSURER PERSPECTIVE
Mar 18, 2026, 21:38 PM -
INDIRECT TREATMENT COMPARISON OF TEPROTUMUMAB VS RITUXIMAB OR TOCILIZUMAB IN PATIENTS WITH MODERATE-TO-SEVERE ACTIVE THYROID EYE DISEASE
Mar 18, 2026, 21:38 PM -
ESTIMATING PRICE ELASTICITIES OF ALCOHOL DEMAND IN CHINA (2010-2024)
Mar 18, 2026, 21:38 PM -
DATA-DRIVEN BASELINE MATCHING: ENHANCING INDIRECT COMPARISONS WITH A MACHINE LEARNING-INFORMED FRAMEWORK FOR SELECTING HOMOGENEOUS TRIAL SETS
Mar 18, 2026, 21:38 PM -
UNIT-CONSISTENT TRANSLATION OF TREATMENT EFFECTS INTO NUMBER NEEDED TO TREAT AND COST PER EVENT AVOIDED IN HEALTH ECONOMIC EVALUATIONS
Mar 18, 2026, 21:38 PM -
PATIENT DESCRIPTIONS OF THE BENEFITS OF A REDUCED CORNSTARCH DOSE REGIMEN IN A PHASE 3 TRIAL OF DTX401 FOR GLYCOGEN STORAGE DISEASE TYPE IA
Mar 18, 2026, 21:38 PM -
DISPARITIES BY SOCIOECONOMIC STATUS IN TIME FROM DIAGNOSIS TO CURATIVE SURGICAL TREATMENT FOR EARLY-STAGE NON-SMALL CELL LUNG CANCER IN U.S. ADULTS
Mar 18, 2026, 21:38 PM -
INCREMENTAL DIRECT AND INDIRECT COSTS OF SJOGREN'S DISEASE IN THE UNITED STATES: A RETROSPECTIVE ANALYSIS USING MARKETSCAN DATABASES
Mar 18, 2026, 21:38 PM -
PHYSICALLY IMPOSSIBLE EFFECTS? PRIOR-PREDICTIVE TESTS SUGGEST MANY BAYESIAN ITCS LACK CREDIBILITY
Mar 18, 2026, 21:38 PM -
ANALYSIS OF THE RELATIONSHIP BETWEEN PHYSICIAN DENSITY AND HEALTHCARE EXPENDITURE IN JAPAN:USING LARGE-SCALE REAL-WORLD DATA OF EMPLOYMENT-BASED HEALTH INSURANCE CLAIMS (WELLNESS STAR DATABASE)
Mar 18, 2026, 21:38 PM -
HEALTHCARE RESOURCE UTILIZATION (HCRU) IN PEDIATRIC PATIENTS WITH HEREDITARY ANGIOEDEMA (HAE) IN THE UNITED STATES: A MATCHED STUDY USING LARGE INSURANCE CLAIMS
Mar 18, 2026, 21:38 PM -
WHEN ONE CODE DEFINES MILLIONS: SENSITIVITY OF PERIPHERAL ARTERY DISEASE COHORTS TO OPERATIONAL DEFINITIONS CHOICES IN REAL-WORLD DATA
Mar 18, 2026, 21:38 PM -
TRENDS IN GUIDELINE-DIRECTED MEDICAL THERAPY AMONG PATIENTS WITH HEART FAILURE WITH REDUCED EJECTION FRACTION
Mar 18, 2026, 21:38 PM -
A COST-CONSEQUENCE ANALYSIS OF NOGAPENDEKIN ALFA INBAKICEPT-PMLN (NAI) IN COMBINATION WITH BACILLUS CALMETTE-GUÉRIN (BCG) VERSUS TAR-200 FOR BCG-UNRESPONSIVE NON-MUSCLE INVASIVE BLADDER CANCER WITH CARCINOMA IN SITU±PAPILLARY DISEASE (NMIBC CIS)
Mar 18, 2026, 21:38 PM
